REQUEST A DEMO
Total
USD $0.00
Search more companies

Ashley Pharmatech Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ashley Pharmatech Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ashley Pharmatech Private Limited is an enterprise in India, with the main office in South Delhi. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on May 13, 2010. From the latest financial highlights, Ashley Pharmatech Private Limited reported a net sales revenue increase of 31.58% in 2024. During that time, Ashley Pharmatech Private Limited’s total assets grew by 61.88%. The net profit margin of Ashley Pharmatech Private Limited increased by 0.1% in 2024.

Legal Address
Khasra No. 24, Farm House No. 103 Vasant Kunj
South Delhi; Delhi; Postal Code: 110070

Contact Details: Purchase the Ashley Pharmatech Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Ashley Pharmatech Private Limited report to view the information.
Financial Auditors:
Purchase the Ashley Pharmatech Private Limited report to view the information.
Incorporation Date:
May 13, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Additional Executive Director
Company Performance
Financial values in the chart are available after Ashley Pharmatech Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
31.58%
Total Operating Revenue
31.58%
Operating Profit
101.82%
EBITDA
67.26%
Net Profit/Loss for the Period
49.67%
Total Assets
61.88%
Total Equity
19.18%
Operating Profit Margin
1.33%
Net Profit Margin
0.1%
Return on Equity (ROE)
3.28%
Debt / Equity
33%
Quick Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?